Compass Opioid Stewardship 2026 Virtual Symposium-FREE NO CME-04-AI Workshop-Quick Hit Application Session-Scott Weiner-Handouts

04-AI Workshop-Quick Hit Application Session-Scott Weiner-Handouts

Pdf Summary

This document is a conference slide deck for the Compass Opioid Stewardship 2026 Conference titled “Artificial Intelligence Demonstration,” presented by Scott G. Weiner, MD, MPH. It includes standard CMS/HHS disclaimers, CME accreditation and credit information (up to 6.5 AMA PRA Category 1 Credits), and disclosure statements noting Dr. Weiner’s consulting relationships (e.g., Vertex Pharmaceuticals and Cessation Therapeutics). The session is framed as educational and quality-improvement focused, and any presented case is anonymized and does not create a provider–patient relationship.<br /><br />The presentation’s learning goals are to (1) demonstrate “ambient AI” scribing tools that listen during clinical encounters and generate clinical notes to reduce documentation burden while preserving accuracy and patient engagement, and (2) apply AI chat tools (large language models and evidence-retrieval platforms) to support everyday primary care decision-making, documentation, and patient communication while recognizing limitations and safety concerns.<br /><br />The agenda covers an ambient scribe demonstration, ChatGPT, and OpenEvidence. Ambient scribes are described as tools that summarize history, exam, and medical decision-making, with costs ranging from free (e.g., Doximity) to several hundred dollars per month. A sample output is shown for a chronic back pain case involving long-term opioid (OxyContin, Vicodin) and benzodiazepine (lorazepam) use, producing structured HPI, exam, and an assessment/plan that raises concerns such as opioid-induced hyperalgesia and proposes dose reduction, buprenorphine consideration, and CBT for anxiety.<br /><br />Potential pitfalls highlighted include obtaining patient permission to record, proofreading, hallucinations, needing to verbalize key details, limited EHR integration and copy/paste burden, and exclusion of small talk. ChatGPT pricing tiers are listed, and OpenEvidence is presented as a free (with NPI) evidence tool. The conclusion emphasizes rapid AI-driven change, predicts ambient scribes will become common, encourages using chatbots with verification, and stresses that clinician compassion cannot be replaced.

Keywords

Compass Opioid Stewardship 2026 Conference

Artificial Intelligence Demonstration

ambient AI scribe

clinical documentation automation

primary care decision support

ChatGPT in healthcare

OpenEvidence evidence retrieval

opioid stewardship and chronic pain

opioid-induced hyperalgesia

buprenorphine and opioid tapering